Research ArticleHuman Studies
Bispecific Monoclonal Antibody-Mediated Targeting of an Indium-111-Labeled DTPA Dimer to Primary Colorectal Tumors: Pharmacokinetics , Biodistribution, Scintigraphy and Immune Response
Jean-Marc Le Doussal, Alain Chetanneau, Anne Gruaz-Guyon, Marie Martin, Emmanuel Gautherot, Paul-Antoine Lehur, Jean-François Chatal, Michel Delaage and Jacques Barbet
Journal of Nuclear Medicine October 1993, 34 (10) 1662-1671;
Jean-Marc Le Doussal
Alain Chetanneau
Anne Gruaz-Guyon
Marie Martin
Emmanuel Gautherot
Paul-Antoine Lehur
Jean-François Chatal
Michel Delaage
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Bispecific Monoclonal Antibody-Mediated Targeting of an Indium-111-Labeled DTPA Dimer to Primary Colorectal Tumors: Pharmacokinetics , Biodistribution, Scintigraphy and Immune Response
Jean-Marc Le Doussal, Alain Chetanneau, Anne Gruaz-Guyon, Marie Martin, Emmanuel Gautherot, Paul-Antoine Lehur, Jean-François Chatal, Michel Delaage, Jacques Barbet
Journal of Nuclear Medicine Oct 1993, 34 (10) 1662-1671;
Bispecific Monoclonal Antibody-Mediated Targeting of an Indium-111-Labeled DTPA Dimer to Primary Colorectal Tumors: Pharmacokinetics , Biodistribution, Scintigraphy and Immune Response
Jean-Marc Le Doussal, Alain Chetanneau, Anne Gruaz-Guyon, Marie Martin, Emmanuel Gautherot, Paul-Antoine Lehur, Jean-François Chatal, Michel Delaage, Jacques Barbet
Journal of Nuclear Medicine Oct 1993, 34 (10) 1662-1671;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Pretargeting: A Path Forward for Radioimmunotherapy
- Current Landscape in Clinical Pretargeted Radioimmunoimaging and Therapy
- Quantitative Immuno-SPECT Monitoring of Pretargeted Radioimmunotherapy with a Bispecific Antibody in an Intraperitoneal Nude Mouse Model of Human Colon Cancer
- Pathology Underrates Colon Cancer Extranodal and Nodal Metastases; Ex vivo Radioimmunodetection Helps Staging
- Bispecific Antibody Pretargeting of Radionuclides for Immuno-Single-Photon Emission Computed Tomography and Immuno-Positron Emission Tomography Molecular Imaging: An Update
- Survival Improvement in Patients With Medullary Thyroid Carcinoma Who Undergo Pretargeted Anti-Carcinoembryonic-Antigen Radioimmunotherapy: A Collaborative Study With the French Endocrine Tumor Group
- Antibody Pretargeting Advances Cancer Radioimmunodetection and Radioimmunotherapy
- Intraperitoneal Pretarget Radioimmunotherapy with CC49 Fusion Protein
- The Direct Route May Not Be the Best Way to Home
- Perspectives on Cancer Therapy with Radiolabeled Monoclonal Antibodies
- Improved Targeting of Pancreatic Cancer: Experimental Studies of a New Bispecific Antibody, Pretargeting Enhancement System for Immunoscintigraphy
- Optimizing Bispecific Antibody Pretargeting for Use in Radioimmunotherapy
- In Vivo Evaluation of Pretargeted 64Cu for Tumor Imaging and Therapy
- Pretargeted Radioimmunotherapy of Cancer: Progress Step by Step
- Successful Surgical Removal of Occult Metastases of Medullary Thyroid Carcinoma Recurrences with the Help of Immunoscintigraphy and Radioimmunoguided Surgery
- Pretargeting of Renal Cell Carcinoma: Improved Tumor Targeting with a Bivalent Chelate